MARTHA BALLARD: Open Payments
NPI 1710163373 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 17 payments from 7 companies in 2025. Trend: 2023 $972 · 2024 $940 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| ABBVIE INC. | 2 | $41 |
| Abbott Laboratories | 1 | $26 |
| Dexcom, Inc. | 1 | $23 |
Products named: JARDIANCE, Kerendia, ZORYVE, Ozempic, FREESTYLE LIBRE, UBRELVY, Dexcom G6 Transmitter, Rybelsus.
Industry payments across TN — which companies pay providers there.
